GoodRx Holdings
GDRX
168 hedge funds and large institutions have $988M invested in GoodRx Holdings in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 40 increasing their positions, 46 reducing their positions, and 32 closing their positions.
53% more call options, than puts
Call options by funds: $6.04M | Put options by funds: $3.95M
19% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 32
4.59% more ownership
Funds ownership: 139.73% → 144.32% (+4.6%)
2% more funds holding
Funds holding: 165 → 168 (+3)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less capital invested
Capital invested by funds: $1.03B → $988M (-$40.7M)
13% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 46
Top Buyers
Top Sellers
GDRX Hedge Fund Activity: Q3 2024 in Review
168 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q3 2024, worth a combined $988M — down 4% from $1.03B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new GDRX positions and 32 closed out — a net gain of 6 holders — while 40 added to existing stakes and 46 trimmed.
The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $29.9M. The largest seller was Schroder Investment Management Group, exiting entirely with an estimated $5.35M sold.
- 168 institutional investors held GoodRx Holdings (GDRX) as of Q3 2024, up from 165 in Q2 2024.
- Funds reported $988M of GoodRx Holdings stock for Q3 2024, down 4% quarter-over-quarter.
- 38 funds opened new GoodRx Holdings positions in Q3 2024 and 32 closed out, a net change of +6 holders.
- The largest GoodRx Holdings buyer in Q3 2024 was T. Rowe Price Investment Management, an estimated $29.9M added.
- The largest GoodRx Holdings seller in Q3 2024 was Schroder Investment Management Group, an estimated $5.35M sold.
Based on aggregated 13F filings for Q3 2024.